angiotensin-II-receptor antagonists
Replacement of angiotensin-converting enzyme inhibitors by       angiotensin-II-receptor antagonists in hypertensive patients with type II       diabetes mellitus: metabolic and hemodynamic consequences.
Replacement of angiotensin-converting enzyme inhibitors by        @SUBJECT$   @PREDICAT$   @OBJECT$  patients with type II       diabetes mellitus: metabolic and hemodynamic consequences.